T. H. Corn

773 total citations
18 papers, 619 citations indexed

About

T. H. Corn is a scholar working on Physiology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, T. H. Corn has authored 18 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in T. H. Corn's work include Neuroscience and Neuropharmacology Research (5 papers), Diet and metabolism studies (4 papers) and Treatment of Major Depression (4 papers). T. H. Corn is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Diet and metabolism studies (4 papers) and Treatment of Major Depression (4 papers). T. H. Corn collaborates with scholars based in United Kingdom, Poland and Germany. T. H. Corn's co-authors include Michael D. Kopelman, Stuart Checkley, Christopher M. Thompson, Nicholas Mallard, E S Johnson, Stephen Taylor, Anne Clarke, Florian Härtig, Ilana B. Glass and Peter Robinson and has published in prestigious journals such as The Lancet, Brain and The British Journal of Psychiatry.

In The Last Decade

T. H. Corn

16 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. H. Corn United Kingdom	9	175	157	157	107	105	18	619
Gustavo Alva United States	15	191 1.1×	233 1.5×	116 0.7×	82 0.8×	78 0.7×	37	957
P. K. Bridges United Kingdom	17	125 0.7×	227 1.4×	266 1.7×	81 0.8×	171 1.6×	41	905
Fuller Rw United States	12	47 0.3×	115 0.7×	257 1.6×	55 0.5×	116 1.1×	49	556
Carol B. Rockett United States	8	134 0.8×	335 2.1×	174 1.1×	97 0.9×	41 0.4×	14	901
Jamie Barnhill United States	15	167 1.0×	113 0.7×	347 2.2×	41 0.4×	52 0.5×	25	870
Deborah K. Hyslop United States	12	106 0.6×	142 0.9×	515 3.3×	101 0.9×	53 0.5×	19	900
R. Scherschlicht Switzerland	13	294 1.7×	88 0.6×	505 3.2×	48 0.4×	108 1.0×	20	861
Laura A. Craig Canada	12	213 1.2×	256 1.6×	180 1.1×	32 0.3×	67 0.6×	13	865
Ana Cervera‐Ferri Spain	15	232 1.3×	95 0.6×	193 1.2×	41 0.4×	77 0.7×	26	803
Nicola Carfagna Italy	11	99 0.6×	153 1.0×	303 1.9×	22 0.2×	65 0.6×	20	634

Countries citing papers authored by T. H. Corn

Since Specialization

Citations

This map shows the geographic impact of T. H. Corn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. H. Corn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. H. Corn more than expected).

Fields of papers citing papers by T. H. Corn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. H. Corn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. H. Corn. The network helps show where T. H. Corn may publish in the future.

Co-authorship network of co-authors of T. H. Corn

This figure shows the co-authorship network connecting the top 25 collaborators of T. H. Corn. A scholar is included among the top collaborators of T. H. Corn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. H. Corn. T. H. Corn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Al‐Mossawi, Hussein, Benjamin A. Fisher, Antoni Chan, et al.. (2024). Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Rheumatology. 6(8). e537–e545. 5 indexed citations

Al‐Mossawi, Hussein, Chris Worth, Patrícia Maria Abreu Machado, et al.. (2021). A first in disease phase 2A trial of granulocyte monocyte colony stimulating factor neutralisation for axial spondyloarthritis (NAMASTE study). Clinical and Experimental Rheumatology. 39(5). 1161–1161.

Checkley, Stuart, T. H. Corn, Ilana B. Glass, et al.. (2007). Neuroendocrine and Other Studies of the Mechanism of Antidepressant Action of Desipramine. Novartis Foundation symposium. 123. 126–147. 1 indexed citations

Clarke, Anne, E S Johnson, Nicholas Mallard, et al.. (2003). A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition. Journal of Neural Transmission. 110(11). 1241–1255. 98 indexed citations

Johnson, E S, Nicholas Mallard, T. H. Corn, et al.. (2003). A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition. Journal of Neural Transmission. 110(11). 1257–1271. 45 indexed citations

Calabrese, Joseph D., C.L. Bowden, Susan L. McElroy, et al.. (1997). Lamictal Monotherapy in the treatment of bipolar disorder. European Neuropsychopharmacology. 1002(7). 3 indexed citations

Calabrese, Joseph D., C.L. Bowden, Susan L. McElroy, et al.. (1997). P.1.133 Lamictal® monotherapy in the treatment of bipolar disorder. European Neuropsychopharmacology. 7. S177–S177. 3 indexed citations

Corn, T. H.. (1990). Reversible Inhibitors of Monoamine Oxidase A: Antidepressants Without Cheese Effect?. International Review of Psychiatry. 2(2). 187–192. 1 indexed citations

Winton, F. R., et al.. (1989). Effects of light treatment upon mood and melatonin in patients with seasonal affective disorder. Psychological Medicine. 19(3). 585–590. 30 indexed citations

10.

Kopelman, Michael D. & T. H. Corn. (1988). CHOLINERGIC ‘BLOCKADE’ AS A MODEL FOR CHOLINERGIC DEPLETION. Brain. 111(5). 1079–1110. 225 indexed citations

11.

Mitchell, Philip B., Jenny Bearn, T. H. Corn, & Stuart Checkley. (1988). Growth Hormone Response to Clonidine After Recovery in Patients with Endogenous Depression. The British Journal of Psychiatry. 152(1). 34–38. 41 indexed citations

12.

Winton, F. R., et al.. (1987). Effects of a phosphodiesterase inhibitor (Rolipram) on the urinary excretion of 6-sulphatoxy melatonin in man. Journal of Psychopharmacology. 1(1). 20–22. 4 indexed citations

13.

Checkley, Stuart, Ilana B. Glass, Christopher M. Thompson, T. H. Corn, & Peter Robinson. (1984). The GH response to clonidine in endogenous as compared with reactive depression. Psychological Medicine. 14(4). 773–777. 56 indexed citations

14.

Corn, T. H., Christopher M. Thompson, & Stuart Checkley. (1984). Effects of Desipramine Treatment upon Central Adrenoceptor Function in Normal Subjects. The British Journal of Psychiatry. 145(2). 139–145. 36 indexed citations

15.

Corn, T. H., et al.. (1984). A Neuroendocrine Study of Stereotactic Sub-Caudate Tractotomy. The British Journal of Psychiatry. 144(4). 417–420. 4 indexed citations

16.

Honer, William G., Ilana B. Glass, Christopher M. Thompson, T. H. Corn, & Stuart Checkley. (1984). Measurement of the GH and other responses to clonidine at different times of the day in normal subjects. Psychoneuroendocrinology. 9(3). 279–284. 6 indexed citations

17.

Corn, T. H., Anthony S. Hale, Christopher M. Thompson, P. K. Bridges, & Stuart Checkley. (1984). A Comparison of the Growth Hormone Responses to Clonidine and Apomorphine in the Same Patients with Endogenous Depression. The British Journal of Psychiatry. 144(6). 636–639. 44 indexed citations

18.

Thompson, Christopher M., Stuart Checkley, T. H. Corn, Christine Franey, & Joséphine Arendt. (1983). DOWN-REGULATION AT PINEAL β-ADRENOCEPTORS IN DEPRESSED PATIENTS TREATED WITH DESIPRAMINE?. The Lancet. 321(8333). 1101–1101. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact